Physician profile
Fernando Rivera Cruz
NPI 1588774111
$87,766.24
in general payments reported to CMS, 2019-2025
9 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $21K · 2021: $17K · 2022: $9,835 · 2023: $17K · 2024: $7,572 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Consulting Fee: $7,500 · Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,581.00 |
| Consulting Fee | $7,500.00 |
| Food and Beverage | $504.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $43,305.10 | 2019-2023 | Alif |
| Medtronic, INC. | $24,143.02 | 2022-2024 | Anteralign Spinal System With Titan Nanolock Surface Technology, Clydesdale Ptc Spinal System, Sonicision |
| Medtronic USA, INC. | $18,773.85 | 2019-2020 | |
| Johnson and Johnson International | $684.87 | 2019-2025 | Ethicon, Dermabond Prineo, Vistaseal |
| Janssen Pharmaceuticals, INC | $566.96 | 2019-2023 | Xarelto |
| Veloxis Pharmaceuticals, INC. | $125.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.41 | 2019 | |
| Abbvie INC. | $28.06 | 2025 | |
| Pbg Puerto Rico LLC | $24.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Rivera Cruz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.